FDA issues draft guidances on next gen sequencing
The FDA has issued two new guidances as part of the President’s Precision Medicine Initiative.
The FDA has issued two new guidances as part of the President’s Precision Medicine Initiative.
Eli Lilly and Company and Boehringer Ingelheim have announced that they are collaborating on a clinical trial in metastatic breast cancer.
Researchers suggest targeted nanosystem drug delivery could be the key to crossing gastrointestinal tract and blood-brain barriers – a prevailing issue with oral medications.